Publications |
1 |
AK ASthana, OP Singh, GC Pant, MS Agarwal. Seminoma of testis with unusual bone metastasis British Journal of Urology.1988; 62(4): 380-381. https://doi.org/10.1111/ PUBMED YES ¡.1464-410X.1988.tb04371.x Cite-4 |
2 |
Asthana AK, Jain RK, Pant GC, Singh OP. Sequential Methotrexate and Radiotherapy in advanced laryngeal cancer. Indian Journal of Otolaryngology 41(3),127-130,1989 |
3 |
S Singh, OP Singh. Fabrication Of water phantom and measurement of central axis percentage depth dose. Journal of Medical Physics.1989;14 (2): 18-20.PUBMED YES |
4 |
K Gupta, OP Singh. A glinicopathologic review of uncommon vascular haemangiopericytomas with follow up and analysis of outcome: A 12 year study European Journal of Cancer supplements .2003;1(5 249-250.PUBMED YES |
5 |
K Gupta, Q Singh, H Ghori . Is high dose rate(HDR) brachytherapy the answer to carcinoma cervix: a pilot study comparing the quality-of-life(QOL) parameters in patients with advanced disease receiving either HDR or loe, dose rate (LDR) brachytherapy after external irradiation. Int | Radiat Oncol Biol Phy. Oct 2003; 57(2):5221-PUBMED YES |
6 |
Yogi V, Singh OP. Induction followed with concurrent chemoradiotherapy in advanced head & neck cancer. I Cancer Res Ther. 2005; 1(4): 198-203. PMID-17998653 PUBMED YES |
7 |
Ruchi Gaur, OP Singh, Milind Kumar, Aarti K Patel, DN Sharma, GK Rath. Comparison of low and high dose rate brachytherapy in carcinoma cervix : Results from a Randomized study. Indian Journal of Clinical Practice.2012; 23(4):203-211. |
8 |
OP. Singh, Gopa Ghosh, Pooja Patil, Veena Khare. Cervical cancer: the present scene. lournal of. Evolution of Medical and Dental Sciences 2013: 2(42): 8099-8109 DQl:10,14250/jemds/1426. |
9 |
Ghosh G, Singh OP.Evaluation of protracted cisplatinum infusion in advanced anaplastic thyroid cancer Int J Med Res Rev 2013; 1(4).doi:10.17511/ümrr.2013.104.004. |
10 |
Yogi V, Singh OP, Tiwari V. Malignant Chondroid Syringoma : A case report with review of literature. RR: J Med Health Scien .2014; 3(2): 29-32 |
11 |
Tiwari V, Singh OP, Ghori HU, Yogi V,Peepre K,Yadav S. Assessment of treatment tolerance and response of elderly head and neck cancer patients: A single institution retrospective study. Clin Cancer Inyestig J. 2015; 4(3): 349. |
12 |
Tiwari V, Singh OP, Ghori HU, Yogi V. Addressing the status of radiotherapy facilities in Bhopal: World leader in mouth cancers. Clip Cancer Inyestig J. 2015; 4(6):777. |
13 |
Tiwari V, Yogi V ,Singh OP, Ghori HU. Identifying the factors causing delayed presentation of cancer patients to a Government Medical College of Central India. I Glin Diag Res.2015; 9(9):9-12. PMID-26500996 PUBMED YES |
14 |
Ghori HU, Tiwari V, Singh OP, Yogi V,Shrivastava A, Mandloi V. Gemcitakine and cisplatin in metastatic carcinoma gall bladder : A single Institution retrospective analysis. I Dent Med Scien.2015; 14(12):9-11. |
15 |
Ghori HU, Tiwari V, Singh OP, Yogi V,Shrivastava A. Nab Paclitaxel and carboplatin as induction chemotherapy in head and neck cancer patients: Efficacy and tolerability. ! Dent Med Scien:2015; 14 (8) 57-60. |
16 |
Shrivastava A, Mandloi V, Tiwari V, Ghori HU, Singh OP, Yogi V. Nab Paclitaxel as induction chemotherapy in external auditory canal carcinoma : Case report and review of literature. Clin Cancer Inyestig J. 2016; 5(1): 76-78. |
17 |
Mandloi V, Shrivastava A, Ghori HU, Tiwari V, Singh OP , Yogi V. Carcinoma buccal mucosa in a treated case of carcinoma cervix : A rare presentation. Clip Cancer Inyestig J. 2016; 5(4):330. |
18 |
Tallari R, Yogi V, Singh OP. Synchronous tuberculosis and breast cancer metastasis in axillary lymph nodes : A case report. Int J Scien Res.2016; 5(2): 319-20. |
19 |
Tallari RV, Singh OP, Yogi V ,Yadav S. Five versus ten fractions per week radiotherapy in locally advanced head and neck cancer. I Cancer Res Ther2917; 13(2) :224-229. PMID-28643738 PUBMED YES |
20 |
Shrivastava A, Ghori HU, Singh OP, Tiwari V, Yogi V. Comparison of toxicities associated with concomitant boost and conventional fractionated radiotherapy regimen in oral and oropharyngeal cancers. I Clin Diagn Res. 2017; 11(10): 1-5. |
21 |
Yogi V ,Narwariya A, Singh OP.Ahirwar, M.Renal cell carcinoma presenting with intraocuhr metastasis- A rare case presentation. International Journal of Advances in Surgery.March 2017;1(2):3-4. |
22 |
Yogi V, Singh OP, Malviya A, Ghori HU. Effect of post-operative time for adjuvant radiotherapy in malignant phyllodes tumor : An Institutional experience. ! Cancer Res Ther2018; Vol 14 (5): 1054-1058. PMID-30197347 PUBMED YES |
23 |
Yogi V, Singh OP, Ahirwar M, Mandloi V. Spectrum of cutaneous metastasis from internal. malignancies: A study of clinico-pathologicaLand survival evaluation.of.126.patients.Int. I Scien. Res.2018: 7(5) 206-208. |
24 |
Yogi V.Lal N, Singh OP. Primary papillary adenocarcinoma of vagina: a rare malignancy. Int! Scien.Res. 2018: 7(7):35 -36. |
25 |
Shrivastava A, Yogi V, Singh OP ,Mandloi V, Choudhary M. The symptom-to-treatment delay in carcinoma cervix : Where we stand among developing countries. Int Scien Res.2018; 7(9) : 54-56. |
26 |
Yogi V, Francis B, Singh OP, Ahirwar M. Unilateral vocal cord paralysis in gastrointestinal malignancies: A rare presentation. International Journal of Scientific Research. 2018; 7 (11): 34-35 |
27 |
Redhu P, Yogi V, Prajapati R, Singh OP. Orbital metastasis in Ewing's sarcoma : A rare cause of proptosis. Int J Scien Res .2018; 7(11) : 60-61. |
28 |
Yogi V, Singh OP, Mandloi V, Ahirwar M. Role of Topical Aloe vera Gel in the Recovery of Higher grade Radiation -induced Dermatitis. Clip Cancer Inyestig J. 2018; 7(5): 167-170. |
29 |
Ahirwar.M.. Yogi V,. Singh OP. Ghori H. Tiwari. V. Francis B. Impact. of Pownstagine with Induction.Chemotherapy. in.Management.of.Locally.Advanced.Squamous Cell Carcinoma of Head.and Neck.clin. Cancer. InyestiR !:2018; 7(6): 221:226. |
30 |
Yogi. V. Mani HP. Singh OP. Ghori.H.Atypical Presentation of.Ewing's Sarcoma, Indian 1 Med Paediatr. Oncol.2019;40:5109-13. |
31 |
Yogi V, Singh OP. Effect of post-operative time for adjuvant radiotherapy in malignant phyllodes tumor : An Institutional experience. I Cancer Res Ther. 2019;15: 1194-5. PMID-31603137 PUBMED YES |
32 |
Singh OP, Yogi V ,Redhu P ,Ghori HU, Pareek A, Lal N. Role of Serum Prostate-specific antigen as Predictor for Bone Metastases in Newly Diagnosed Prostate cancer. I Cancer Res Ther 2019:15:539-41.PMID-30900618 PUBMED YES |
33 |
Yogi.. Singh.OP. Redbu P. Erancis. B. Extrangdal Non:Hodekin.lymphomas: The impact of Pifferent.Variables.on the Disease: Middle East I cancer. October. 2019;10(4): 32.4-332. |
34 |
Ahirwar M, Yogi V, Singh OP. A Randomized prospective comparative study of single versus combination chemo-radiation in locally advanced head and neck cancers. Cancer Ther 2ncol Int J. July 2019; 14(3): 001-005.D0110.19080/CTONJ.2019.14.555890 |
35 |
Yadav S, Chandel SS, Choudhary S, Yogi V, Singh OP, Dinesh KS, Goswami B. Dosimetric analysis of 3D-CT image based high dose rate brachytherapy treatment planning of carcinoma utefine cervix: Initial experiences at Central India Government Institute. I Cancer Sci Ther. 2019; 11(8):244-250. |
36 |
Pareek A, Singh OP , Yogi V, Ghori HU, Tiwari V. Bone metastases incidence and its correlation with hormonal and Her?-ney receptors in breast cancer. I Cancer Res Ther .2019;15: 971-5.PMID-31603096 PUBMED YES |
37 |
Mandloi V, Yogi V, Singh OP, Ahirwar M, Yadav S, Ghori HU. A Comparative Study of NabPaclitaxel versus Cisplatin Concurrent Chemoradiotherapy, in Locally Advanced Cervical Cancer, dio.Cancer. Joyestig. 1.2019;8:198 |
38 |
Yadav S, Singh OP, Choudhary S, Saroj DK, Maurya AK, Yogi V. Interfraction Physical dose variations in high-dose-rate brachytherapy for carcinoma cervix based on computed tomography image dataset to find the compatibility of the first fraction plan to treat successive fractions. I Can Res Ther2019; 15: 1304-8 .PMID-31898664 PUBMED YES |
39 |
Jame R, Ghori H, Singh O, Tiwari V, Shrivastava A. Comparison of two multifraction radiotherapy schedules in management of painful bone metastases: A single institution prospective study. Niger I Slip Prat 2019;22:1539-45. |
40 |
Yadav S, Choudhary S, Singh OP, Dinesh KS. Dosimetric comparison of two type brachytherapy planning approaches in HDR treatment of carcinoma uterine cervix: Standard library plan approaches vs. 3DCT image based planning. Anusandhan Science Technology and Management Journal.Sept 2019;9(17). |
41 |
Yadav S, Singh OP, Choudhary S, Dinesh KS, Yogi V, Goswami B. Estimation and comparison of integral dose to target and organ at risks in 3D CT image based treatment planning of carcinoma uterine cervix with two HDR brachytherapy sources : 60 Co 192 Ir. J Cancer Res Ther.DO1:10.4103/iertJCRT_129_19 PUBMED YES |